← Open Payments lookup

MARANDA DILLON: Open Payments

NPI 1376072413 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$130,137 in 303 payments from 14 companies in 2025. Trend: 2023 $5,962 · 2024 $56,509 · 2025 $130,137

Speaker / faculty: $78,539Travel & lodging: $35,899Food & beverage: $7,181Consulting: $5,769Honoraria: $2,728Education: $20
CompanyPaymentsAmount
Janssen Biotech, Inc.135$84,192
Takeda Pharmaceuticals U.S.A., Inc.40$17,764
ABBVIE INC.56$14,329
Lilly USA, LLC16$5,515
Celltrion USA Inc.14$3,338
Genentech USA, Inc.4$2,768
Janssen Scientific Affairs, LLC14$878
Merck Sharp & Dohme LLC7$729
PFIZER INC.8$444
Madrigal Pharmaceuticals3$72

Products named: TREMFYA, ENTYVIO, SKYRIZI, RINVOQ, OMVOH, ZYMFENTRA, STELARA, VELSIPITY.

Industry payments across MS — which companies pay providers there.